Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicity.

Our study demonstrates that when used separately or in conjunction with other evidence, tumour characteristics provide evidence for germline MMR missense variant assessment, which may have important implications for genetic testing and clinical management.